Takeda to Move Forward with $2.3 Billion Actos Settlement

September 15th, 2015- A month ago, it seemed that Takeda might not get enough takers to move forward with its generous $2.3 billion offer to settle thousands of claims over...

Feds Investigation of the Power Morcellator link to Cancer Deaths

In a previous article regarding power morcellators, we reported that the Government Accountability Office was urged by Congress to launch an investigation into the dangers of the power morcellator. It...

FDA Revises Invokana Label to Include Bone Fracture Risk

September 10th, 2015- The FDA has strengthened the warning for the type 2 diabetes drug Invokana related to the increased risk of bone fractures and added new information about decreased bone...

Canadian Study Reveals Further Surgery for Mesh Patients

September 10, 2015- According to a new study, Canadian women  who received vaginal mesh to treat incontinence had a one in 30 chance they would need to have the mesh removed...

What to Expect at the Essure FDA Panel

San Diego, CA September 9, 2015-- On September 24 the FDA will convene to review and evaluate data concerning the safety and effectiveness of Essure, a permanent birth control device...

What to Expect at the Essure FDA Panel

San Diego, CA September 9, 2015-- On September 24 the FDA will convene to review and evaluate data concerning the safety and effectiveness of Essure, a permanent birth control device...

C.R. Bard Gives Little Weight to IVC Complications

San Diego, CA September 4, 2015 -- C.R. Bard is facing heat over it's blood-clot device, the IVC Filter. Reports have surfaced that IVC filters caused serious injuries, and in...

What are the Essure Complications?

San Diego, CA September 3, 2015 -- Women, like Kama Sales, were attracted to Essure because of the marketing that it’s a simple procedure with a quick recovery. Kama Sales...

Essure Problems – Essure Issues

September 1, 2015 -- San Diego, CA Essure, the permanent birth control marketed to women, is stirring up controversy about its problems. While it’s marketed as a simple, quick solution...

Janssen Accused of Hiding Risperdal Autism Data

Janssen Pharmaceuticals, the manufacturer of Risperdal, which is widely used in autistic children, willingly withdrew data on its side effects from a 2003 study, according to evidence presented in a...